AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 59 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $22,625,330 | +82.3% | 1,513,400 | +0.4% | 0.00% | – |
| Q3 2022 | $12,410,000 | +26.0% | 1,507,955 | +0.4% | 0.00% | – |
| Q2 2022 | $9,848,000 | +17.3% | 1,501,317 | 0.0% | 0.00% | – |
| Q1 2022 | $8,392,000 | +22.1% | 1,501,317 | +2.5% | 0.00% | – |
| Q4 2021 | $6,871,000 | -23.7% | 1,465,107 | +0.6% | 0.00% | – |
| Q3 2021 | $9,000,000 | -5.7% | 1,456,230 | +0.6% | 0.00% | – |
| Q2 2021 | $9,541,000 | -5.0% | 1,447,686 | +5.5% | 0.00% | – |
| Q1 2021 | $10,046,000 | +39.0% | 1,372,537 | +9.6% | 0.00% | – |
| Q4 2020 | $7,225,000 | +10.7% | 1,252,147 | +14.0% | 0.00% | – |
| Q3 2020 | $6,524,000 | +16.8% | 1,098,349 | +1.3% | 0.00% | – |
| Q2 2020 | $5,584,000 | +135.8% | 1,084,266 | +65.8% | 0.00% | – |
| Q1 2020 | $2,368,000 | – | 654,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PATHWAY CAPITAL MANAGEMENT, LP | 245,606 | $3,671,810 | 6.55% |
| AIGH Capital Management LLC | 695,358 | $10,395,602 | 3.42% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 638,360 | $9,544 | 2.08% |
| Kellner Capital, LLC | 100,016 | $1,495 | 1.74% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,464,807 | $21,898,865 | 1.70% |
| Worth Venture Partners, LLC | 170,925 | $2,555,329 | 1.51% |
| Birchview Capital, LP | 100,000 | $1,495 | 1.06% |
| BCK CAPITAL MANAGEMENT LP | 68,000 | $1,016,600 | 1.05% |
| WATER ISLAND CAPITAL LLC | 698,915 | $10,449 | 0.89% |
| EHP Funds Inc. | 292,043 | $4,366 | 0.82% |